Stocktwits on MSN
Eli Lilly’s oral obesity drug passes maintenance test after Wegovy, Zepbound — Wall Street flags win for Viking Therapeutics
The company studied Orforglipron for weight maintenance over 52 weeks in patients who were on 72 weeks of popular injectable ...
Nektar Therapeutics is advancing Rezpeg in atopic dermatitis and alopecia areata. Click here for key insights on NKTR's ...
Check out a month-by-month breakdown of the major events affecting the pharma and medical marketing industries in 2025.
Orforglipron helped keep weight down when used after initial therapy with an injectable, a new treatment strategy that could ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results